Kidney Research and Clinical Practice

Korean Society of Nephrology (대한신장학회)
권호 표지
DOI QR코드

DOI QR Code

Cystatin C as a novel predictor of preterm labor in severe preeclampsia

  • Received : 2018.07.25
  • Accepted : 2018.08.29
  • Published : 2018.12.31
⟨ Previous Next ⟩

Abstract

Background: The most common cause of acute kidney injury (AKI) in pregnancy is preeclampsia. Serum cystatin C (CysC) is a potential biomarker of early kidney damage as its levels are not disturbed by volume status changes in pregnancy, and serum CysC levels could serve as a replacement for conventionally used creatinine. In this study, we investigated the serum levels of CysC in severe preeclampsia cases and the associations between CysC levels and poor obstetric outcomes. Methods: Our cohort included severe preeclampsia patients with a normal serum creatinine level. Creatinine was measured to calculate estimated glomerular filtration rate (eGFR) based on the Cockcroft and Gault, Modification of Diet in Renal Disease Study (MDRD), and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations, while CysC was measured to calculated eGFR based on a CysC-based equation. We then evaluated the correlations between serum CysC level, eGFR, and obstetric outcomes. Results: Twenty-six patients were evaluated of which 38.5% delivered preterm and 30.8% had low-birth weight babies. Unlike creatinine-based eGFR and CysC-based eGFR, serum CysC demonstrate significant negative correlation with gestational age. Receiver operating characteristic curve analysis indicated that serum CysC is a potential biomarker of preterm delivery with a cut-off serum level of 1.48 mg/L with 80% sensitivity and 75% specificity. Conclusion: GFR estimation using CysC is likely to be inaccurate in pregnancy. However, we found a significant correlation between preterm delivery and serum CysC level. Our results suggest that serum CysC level has the potential to predict preterm delivery in severe preeclampsia patients.

Keywords

References

  1. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ 347:f6564, 2013 https://doi.org/10.1136/bmj.f6564
  2. Saleem S, McClure EM, Goudar SS, et al. A prospective study of maternal, fetal and neonatal deaths in low- and middle-income countries. Bull World Health Organ 1:605- 612, 2014
  3. Souza JP, Gulmezoglu AM, Vogel J, et al. Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study. Lancet 381:1747-1755, 2013 https://doi.org/10.1016/S0140-6736(13)60686-8
  4. Hansen AR, Barnes CM, Folkman J, McElrath TF. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr 156:532-536, 2010 https://doi.org/10.1016/j.jpeds.2009.10.018
  5. Strand KM, Heimstad R, Iversen AC, et al. Mediators of the association between pre-eclampsia and cerebral palsy: population based cohort study. BMJ 347:f4089, 2013 https://doi.org/10.1136/bmj.f4089
  6. Prakash J, Ganiger VC, Prakash S, et al. Acute kidney injury in pregnancy with special reference to pregnancy-specific disorders: a hospital based study (2014-2016). J Nephrol 31:79-85, 2018 https://doi.org/10.1007/s40620-017-0466-y
  7. Alge JL, Arthur JM. Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications. Clin J Am Soc Nephrol 10:147-155, 2015 https://doi.org/10.2215/CJN.12191213
  8. Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol 48:463-493, 2008 https://doi.org/10.1146/annurev.pharmtox.48.113006.094615
  9. Jim B, Garovic VD. Acute kidney injury in pregnancy. Semin Nephrol 37:378-385, 2017 https://doi.org/10.1016/j.semnephrol.2017.05.010
  10. Kreepala C, Luangphiphat W, Villarroel A, Kitporntheranunt M, Wattanavaekin K, Piyajarawong T. Effect of magnesium on glomerular filtration rate and recovery of hypertension in women with severe preeclampsia. Nephron 138:35-41, 2018 https://doi.org/10.1159/000481463
  11. Kreepala C, Kitporntheranunt M, Sangwipasnapaporn W, Rungsrithananon W, Wattanavaekin K. Assessment of preeclampsia risk by use of serum ionized magnesium-based equation. Ren Fail 40:99-106, 2018 https://doi.org/10.1080/0886022X.2017.1422518
  12. Chapman AB, Abraham WT, Zamudio S, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 54:2056-2063, 1998 https://doi.org/10.1046/j.1523-1755.1998.00217.x
  13. Huang C, Chen S. Acute kidney injury during pregnancy and puerperium: a retrospective study in a single center. BMC Nephrol 18:146, 2017 https://doi.org/10.1186/s12882-017-0551-4
  14. Smith MC, Moran P, Ward MK, Davison JM. Assessment of glomerular filtration rate during pregnancy using the MDRD formula. BJOG 115:109-112, 2008
  15. Siew ED, Ware LB, Ikizler TA. Biological markers of acute kidney injury. J Am Soc Nephrol 22:810-820, 2011 https://doi.org/10.1681/ASN.2010080796
  16. Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez- Bru C, Grubb A. Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem 38:1-8, 2005 https://doi.org/10.1016/j.clinbiochem.2004.09.025
  17. Roos JF, Doust J, Tett SE, Kirkpatrick CM. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis. Clin Biochem 40:383-391, 2007 https://doi.org/10.1016/j.clinbiochem.2006.10.026
  18. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40:221-226, 2002 https://doi.org/10.1053/ajkd.2002.34487
  19. Zappitelli M, Greenberg JH, Coca SG, et al. Association of definition of acute kidney injury by cystatin C rise with biomarkers and clinical outcomes in children undergoing cardiac surgery. JAMA Pediatr 169:583-591, 2015 https://doi.org/10.1001/jamapediatrics.2015.54
  20. Yalcin S, Ulas T, Eren MA, et al. Relationship between oxidative stress parameters and cystatin C levels in patients with severe preeclampsia. Medicina (Kaunas ) 49:118-123, 2013
  21. Niraula A, Lamsal M, Baral N, et al. Cystatin-C as a marker for renal impairment in preeclampsia. J Biomark 2017: 7406959, 2017
  22. Abitbol CL, Seeherunvong W, Galarza MG, et al. Neonatal kidney size and function in preterm infants: what is a true estimate of glomerular filtration rate? J Pediatr 164:1026-1031, 2014 https://doi.org/10.1016/j.jpeds.2014.01.044
  23. Gursoy AY, Tasci Y, Celik H, et al. The prognostic value of first-trimester cystatin C levels for gestational complications. J Perinat Med 44:295-299, 2016
  24. Risch M, Purde MT, Baumann M, et al. High first-trimester maternal blood cystatin C levels despite normal serum creatinine predict pre-eclampsia in singleton pregnancies. Scand J Clin Lab Invest 77:634-643, 2017 https://doi.org/10.1080/00365513.2017.1393692
  25. Buderer NM. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med 3:895-900, 1996 https://doi.org/10.1111/j.1553-2712.1996.tb03538.x
  26. Ngwenya S. Severe preeclampsia and eclampsia: incidence, complications, and perinatal outcomes at a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe. Int J Womens Health 9:353-357, 2017 https://doi.org/10.2147/IJWH.S131934
  27. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 365:785-799, 2005 https://doi.org/10.1016/S0140-6736(05)17987-2
  28. Howson CP, Kinney MV, McDougall L, Lawn JE; Born Too Soon Preterm Birth Action Group. Born too soon: preterm birth matters. Reprod Health 10 Suppl 1:S1, 2013 https://doi.org/10.1186/1742-4755-10-S1-S1
  29. Lee AC, Kozuki N, Cousens S, et al. Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH- 21st standard: analysis of CHERG datasets. BMJ 358:j3677, 2017
  30. Kiserud T, Benachi A, Hecher K, et al. The World Health Organization fetal growth charts: concept, findings, interpretation, and application. Am J Obstet Gynecol 218:S619- S629, 2018 https://doi.org/10.1016/j.ajog.2017.12.010
  31. Al-Turki HA, Abu-Heija AT, Al-Sibai MH. The outcome of pregnancy in elderly primigravidas. Saudi Med J 24:1230-1233, 2003
  32. Wall-Wieler E, Roos LL, Nickel NC. Adolescent pregnancy outcomes among sisters and mothers: a population-based retrospective cohort study using linkable administrative data. Public Health Rep 133:100-108, 2018 https://doi.org/10.1177/0033354917739583
  33. Inker LA, Schmid CH, Tighiouart H, et al; CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367:20-29, 2012 https://doi.org/10.1056/NEJMoa1114248
  34. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604-612, 2009 https://doi.org/10.7326/0003-4819-150-9-200905050-00006
  35. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247-254, 2006 https://doi.org/10.7326/0003-4819-145-4-200608150-00004
  36. National Kidney Foundation, Inc. GFR Calculator. Available at: https://www.kidney.org/professionals/kdoqi/gfr_calculator.
  37. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976 https://doi.org/10.1159/000180580
  38. Mundt LA, Shanahan K. Chemical analysis of urine. In: Mundt LA, Shanahan K, eds. Graff 's Textbook of Routine Urinalysis and Body Fluids, 2nd edition. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health, 35-54, 2010
  39. Kattah AG, Garovic VD. The management of hypertension in pregnancy. Adv Chronic Kidney Dis 20:229-239, 2013 https://doi.org/10.1053/j.ackd.2013.01.014
  40. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 183:S1-S22, 2000 https://doi.org/10.1016/S0002-9378(00)99785-0
  41. Padma Y, Aparna VB, Kalpana B, Ritika V, Sudhakar PR. Renal markers in normal and hypertensive disorders of pregnancy in Indian women: a pilot study. Int J Reprod Contracept Obstet Gynecol 2:514-520, 2013 https://doi.org/10.5455/2320-1770.ijrcog20131205
  42. Strevens H, Wide-Swensson D, Grubb A. Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate. Scand J Clin Lab Invest 61:575-580, 2001 https://doi.org/10.1080/003655101753218346
  43. Franceschini N, Qiu C, Barrow DA, Williams MA. Cystatin C and preeclampsia: a case control study. Ren Fail 30:89- 95, 2008 https://doi.org/10.1080/08860220701742229
  44. Babay Z, Al-Wakeel J, Addar M, et al. Serum cystatin C in pregnant women: reference values, reliable and superior diagnostic accuracy. Clin Exp Obstet Gynecol 32:175-179, 2005
  45. Novakov Mikic A, Cabarkapa V, Nikolic A, et al. Cystatin C in pre-eclampsia. J Matern Fetal Neonatal Med 25:961-965, 2012 https://doi.org/10.3109/14767058.2011.601366
  46. Bjornstad P, Cherney DZI. Kidney function can predict pregnancy outcomes. Clin J Am Soc Nephrol 12:1029-1031, 2017 https://doi.org/10.2215/CJN.04970517
  47. Piccoli GB, Attini R, Vasario E, et al. Pregnancy and chronic kidney disease: a challenge in all CKD stages. Clin J Am Soc Nephrol 5:844-855, 2010 https://doi.org/10.2215/CJN.07911109
  48. Sturgiss SN, Wilkinson R, Davison JM. Renal reserve during human pregnancy. Am J Physiol 271(1 Pt 2):F16-F20, 1996
  49. Nevis IF, Reitsma A, Dominic A, et al. Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin J Am Soc Nephrol 6:2587-2598, 2011 https://doi.org/10.2215/CJN.10841210
  50. Piccoli GB, Cabiddu G, Attini R, et al. Risk of adverse pregnancy outcomes in women with CKD. J Am Soc Nephrol 26:2011-2022, 2015 https://doi.org/10.1681/ASN.2014050459
  51. Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65:1416-1421, 2004 https://doi.org/10.1111/j.1523-1755.2004.00517.x
  52. Chu SC, Wang CP, Chang YH, et al. Increased cystatin C serum concentrations in patients with hepatic diseases of various severities. Clin Chim Acta 341:133-138, 2004 https://doi.org/10.1016/j.cccn.2003.11.011
  53. Fricker M, Wiesli P, Brandle M, Schwegler B, Schmid C. Impact of thyroid dysfunction on serum cystatin C. Kidney Int 63:1944-1947, 2003 https://doi.org/10.1046/j.1523-1755.2003.00925.x
  54. Wiesli P, Schwegler B, Spinas GA, Schmid C. Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta 338:87-90, 2003 https://doi.org/10.1016/j.cccn.2003.07.022
  55. Tan GD, Lewis AV, James TJ, et al. Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care 25:2004-2009, 2002 https://doi.org/10.2337/diacare.25.11.2004
  56. Xia LH, Bing XG, An XT. Serum cystatin C assay for the detection of early renal impairment in diabetic patients. J Clin Lab Anal 18:31-35, 2004 https://doi.org/10.1002/jcla.20005
  57. O'Riordan SE, Webb MC, Stowe HJ, et al. Cystatin C improves the detection of mild renal dysfunction in older patients. Ann Clin Biochem 40:648-655, 2003 https://doi.org/10.1258/000456303770367243
  58. Curhan G. Cystatin C: a marker of renal function or something more? Clin Chem 51:293-294, 2005 https://doi.org/10.1373/clinchem.2004.044388
  59. Koenig W, Twardella D, Brenner H, Rothenbacher D. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 51:321-327, 2005 https://doi.org/10.1373/clinchem.2004.041889

Cited by

  1. Extracellular vesicles: a novel window into kidney function and disease vol.29, pp.6, 2018, https://doi.org/10.1097/mnh.0000000000000641
  2. Acute kidney injury in patients operated on for type A acute aortic dissection: incidence, risk factors and short-term outcomes vol.31, pp.5, 2018, https://doi.org/10.1093/icvts/ivaa164